Our Publications
Menu
The C4 Centre for Research Excellence has coordinated research and evaluation activities in cervical cancer control, which has enabled the C4 to significantly contribute to the national and global evidence-base and peer reviewed literature in all aspects of cervical cancer control since its formation in 2017.
2021
- Accelerating action on cervical screening in lower- and middle-income countries (LMICs) post COVID-19 era. Preventive Medicine.
- Health care provider perspectives on cervical screening for Aboriginal and Torres Strait Islander women: a qualitative study. ANZJPH.
- Australian National Cervical Screening Program Renewal: attitudes and experiences of General Practitioners, and Obstetricians and Gynaecologists. Aust NZ J Obstet Gynaecol.
- Surveillance systems for monitoring cervical cancer elimination efforts: focus on HPV infection, cervical dysplasia, cervical screening and treatment. Prev Med.
- Current and future vaccine clinical research with the licensed 2-, 4-, and 9-valent VLP HPV vaccines: What’s ongoing, what’s needed? Prev Med.
- Immunology of HPV Infection and Vaccination: Progress and Challenges. Frontiers in Immunology.
- Human Papillomavirus Vaccination After COVID-19. JNCI Cancer Spectrum.
- Achieving cervical cancer elimination among Indigenous women. Prev Med.
- Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis. Prev Med.
- Human Papillomavirus Vaccination for Adults Aged 30-45 Years in the United States: A Cost-Effectiveness Analysis. PLoS Med.
- Impact of COVID-19-related care disruptions on cervical cancer screening in the United States. J Med Screen.
- Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control. Int J Cancer.
- Active surveillance as a management option for cervical intraepithelial neoplasia 2: an online randomised experimental study. Gynecologic Oncology.
- Effect of a School-Based Educational Intervention About the Human Papillomavirus Vaccine on Psychosocial Outcomes Among Adolescents: Analysis of Secondary Outcomes of a Cluster Randomized Trial. JAMA Netw Open.
- Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2020. Communicable Diseases Intelligence.
- Self-collection cervical screening in the renewed National Cervical Screening Program: a qualitative study. Med J Aust.
- Human papillomavirus prevalence and risk factors among Australian women 9–12 years after vaccine program introduction. Vaccine .
- Program ROSE: a revolutionary strategy in cervical screening. HPV World.
- Yarning about HPV Vaccination: a qualitative study of factors influencing HPV vaccination among Aboriginal and Torres Strait Islander adolescents in Australia. BMJ Open.
- Differences in school factors associated with adolescent HPV vaccination initiation and completion coverage in three Australian states. Vaccine.
- The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support. International Journal of Cancer.
- Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologists. Aust N Z J Obstet Gynaecol.
- School-based HPV vaccination positively impacts parents’ attitudes toward adolescent vaccination. Vaccine.
- National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol. Systematic Reviews.
- Evaluation of the Roche MagNA Pure 96 nucleic acid extraction platform for the Seegene Anyplex II HPV28 detection assay.
- Vaccinations in patients with multiple sclerosis: review and recommendations. Med J Aust.\
- Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient? Tumour Virus Research.
2020
- Getting the timing right: women’s views on the best time to announce changes to cancer screening policy recommendations. Prev Med Rep.
- Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled Analysis. Cancer Epidemiol Biomarkers Prev.
- Health Economic evaluation of primary human papillomavirus screening in urban populations in China. Cancer Epidemiol.
- The Past, Present and Future Impact of HIV Prevention and Control on HPV and Cervical Disease in Tanzania: A Modelling Study. PLoS One.
- Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia. J Infect Dis
- Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. The Lancet.
- More Evidence Suggesting That 1-Dose Human Papillomavirus Vaccination May Be Effective. Cancer.
- Understanding the proportion of cervical cancers attributable to HPV. The Medical Journal of Australia (MJA).
- Projected time to elimination of cervical cancer in the USA: a comparative modelling study. The Lancet.
- Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet.
- Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet.
- Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening. Vaccine.
- Implementation of Australia’s renewed cervical screening program: Preparedness of general practitioners and nurses. PLOS ONE.
- Compliance with follow-up Test of Cure and outcomes after treatment for high-grade cervical intraepithelial neoplasia in Victoria, Australia. The Australian and New Zealand Journal of Obstetrics and Gynaecology (ANZJOG).
- Evaluation of p16/Ki-67 dual stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer. Clinical Microbiology and Infection.
- Compliance with follow-up Test of Cure and outcomes after treatment for high-grade cervical intra-epithelial neoplasia in Victoria. Aust N Z J Obstet Gynaecol
- IPVS policy statement equity in cervical cancer prevention: For all and not just for some. Papillomavirus Research.
- IPVS Policy Statement addressing the burden of HPV disease for Indigenous peoples. Papillomavirus Research.
- Levels of anxiety and distress after screening positive in Australia’s HPV-based cervical screening program. Sex Transm Infect.
- Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia by the Australian Technical Advisory Group on Immunisation (ATAGI). Commun Dis Intell.
- Analytical performance of HPV assays on vaginal self-collected vs practitioner-collected cervical samples: the SCoPE study. Journal of Clinical Virology.
- The value of data linkage depends on the quality of the data: incorporating Medicare data alters cervical screening analysis findings. MJA.
- Self-Collection for Cervical Screening Programs: From research to reality. Cancers
- Indigenous Australian women’s experiences of participation in cervical screening. PLoS ONE.
- Increased risk of cervical dysplasia in females with autoimmune conditions—Results from an Australia database linkage study. PLoS ONE.
- Adverse events following HPV vaccination: 11 years of surveillance in Australia. Vaccine.
- Understanding the participation of breast screening among women born in predominantly Muslim countries living in Victoria, Australia from record-linkage data. PLoS One.
- HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination. Vaccine.
- Assessment of attribution algorithms for resolving CIN3-related HPV genotype prevalence in mixed-genotype biopsy specimens using laser capture microdissection as the reference standard. Vaccine.
- Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study. BJOG.
- Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2019. Commun Dis Intell.
- Recurrent Post Coital Bleeding: Should colposcopy still be mandatory? Aust N Z J Obstet Gynaecol.
- Getting the timing right: women’s views on the best time to announce changes to cancer screening policy recommendations. Preventive Medicine Reports.
- Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females. Sexual Health.
- Response to: HPV swab self‐collection and cervical cancer in women who have sex with women. Med. J. Aust.
- Performance measures for Australian laboratories reporting cervical cytology 2009–2017: the impact of the national HPV vaccination program. Pathology.
- Uptake and acceptability of human papillomavirus self-sampling in rural and remote Aboriginal communities: evaluation of a nurse-led community engagement model. BMC Health Serv Res.
- Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis. Lancet Glob Health.
- Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions. Gynecol Oncol.
- The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction. (MCLIR) Methodology.
- Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence. Br J Cancer.
- Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis. J Natl Cancer Inst.
- Low-risk Human Papillomavirus: Genital Warts, Cancer and Respiratory Papillomatosis, Chapter 10, Human Papillomavirus.
- Clinical Trials of human papillomavirus vaccines, Chapter 19, Human Papillomavirus.
- Twelve years of vaccine registration and the consequences, Chapter 21, Human Papillomavirus.
- A significant measure of HPV vaccine effectiveness in a high-risk population in Korea prior to a national immunization program. Journal of Gynecologic Oncology.
- Temporary HPV vaccine shortage: Implications globally to achieve equity. Papillomavirus Research.
- A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination. Vaccine.
- Prevalence, incidence and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial. Papillomavirus Research.
- Detection of high-grade cervical disease among women referred to colposcopy following a positive HPV screening test varies with age and cytology findings. International Journal of Cancer Research.
- Cervical cancer in transgender men: a review. BJOG.
- hTERT protetin expression in cytoplasm and nucleus and its association with HPV infections in patients with cervical cancer. Cancer Genomics and Protocols.
- How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia. Public Health Res Pract.
- Has HPV vaccination prevented adverse pregnancy outcomes? Population level analysis after eight years of a National HPV Vaccination Program in Australia. J Infect Dis.
- Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy. Gynecol Oncol.
- Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women. Am J Obstet Gynecol.
- Australia should lead on Pacific cervical cancer elimination – Devpolicy Blog from the Development Policy Centre.
- Qualitative Evidence Synthesis on Self-Collection for Human Papillomavirus-Based Cervical Screening: Protocol for Systematic Review. JMIR Res Protoc.
2019
- Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study. The Australian and New Zealand Journal of Obstetrics and Gynaecology (ANZJOG).
- Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis. Papillomavirus Research.
- Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. The Lancet.
- HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015. The Medical Journal of Australia (MJA).
- Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions. CLIMACTERIC.
- Impact of HPV vaccination: Achievements and future challenges. Papillomavirus Research.
- The remarkable impact of bivalent HPV vaccine in Scotland. BMJ.
- Evaluation of self-collected vaginal specimens for the detection of high-risk HPV infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting. Clinical Microbiology and Infection.
- Age-specific HPV prevalence among 116,052 women in Australia’s renewed cervical screening program: A new tool for monitoring vaccine impact. Vaccine.
- Lessons from the renewal of the National Cervical Screening Program in Australia. Public Health Res Pract.
- Management and long‐term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study. Aust N Z J Obstet Gynaecol.
- Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia. Gynecologic Oncology.
- Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination? Int J Cancer.
- The projected timeframe until cervical cancer elimination in Australia. Lancet Public Health.
- Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening. J Clin Microbiol.
- Development and application of a framework to estimate health care costs in China: The cervical cancer example. PLoS ONE.
- HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Res.
- Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health.
- Cancer costs and gender: a snapshot of issues, trends, and opportunities to reduce inequities using Australia as an example. Climacteric.
- Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates. Public Health.
- Towards the global elimination of cervical cancer. Papillomavirus Res. 2019.
- The burden of cervical cancer in Vietnam: Synthesis of the evidence. Cancer Epidemiol.
- The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications. Gynecol Oncol.
- Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study. Lancet Oncol.
- Population level impact and herd effects following the introduction of HPV vaccination programs: updated systematic review and meta-analysis, The Lancet.
- Recombinant HPV 9-valent vaccine in the prevention of cancers caused by HPV, invited review. Infection and Drug Resistance Journal.
- 9-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population. Gynecologic Oncology.
- Awareness of HPV cervical cancer and its prevention amongst primigravid antenatal clinic attendees in a tertiary care hospital in Sri Lanka: A cross sectional study. Sexual Health.
- Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies. Cancer Medicine.
- Routine cervical screening by primary HPV testing: Early observations from the renewed National Cervical Screening program. The Medical Journal of Australia, (MJA).
- HPV genoprevalence and HPV knowledge in young women in Mongolia, 5 years following a pilot 4-valent HPV vaccine campaign. Papillomavirus Research.
- Prevalence of HPV in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia; 2014-2017. Vaccine.
- Human papillomavirus testing as part of the renewed National Cervical Screening Program. . Australian Journal of General Practice.
- HPV vaccination in Papua New Guinea to prevent cervical cancer in women: Gender, sexual morality, outsiders and the de-feminization of the HPV vaccine. Papillomavirus Res.
- Immunisation coverage annual report, 2017. Commun Dis Intell.
- Rationalizing the HPV vaccination schedule: a long road to a worthwhile destination. Papillomavirus Research.
- Understanding the participation of cervical cancer screening among Muslim women in Victoria, Australia from record-linkage data. Journal of Cancer Policy.
- Australian Paediatric Surveillance Unit Annual Report 2018. Commun Dis Intell.
- Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2011-2015.
- HPV vaccination coverage and course completion rates among Aboriginal and Torres Strait Islander adolescents. Med J Aust.
- Cancer management in the Pacific region: a report on innovation and good practice. Lancet Oncol.
2018
- Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea. Papillomavirus Research.
- Aboriginal women have a higher risk of cervical abnormalities at screening; South Australia, 1993-2016. J Med Screen.
- Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening. J Clin Microbiol.
- Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programs. J Am Soc Cytopathol.
- The projected timeframe until cervical cancer elimination in Australia. Lancet PH.
- Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: example from New Zealand. Vaccine.
- Should cervical cancer screening be performed before age 25? J Low Genit Tract Dis.
- The impact of ten years of HPV vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill.
- Australian Paediatric Surveillance Unit Annual Report, 2017. Commun Dis Intell Q Rep.
- Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia. Cancer Epidemiol.
- Human papillomavirus vaccination update: nonavalent vaccine and the two-dose schedule. Australian Journal of General Practice.
- Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study. Vaccine.
- Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention. JMIR Res Protoc.
- Cervical screening in HPV-vaccinated populations. Climacteric.
- IPVS Statement Moving towards Elimination of Cervical Cancer as a Public Health Problem. Papillomavirus Research.
- Spatial variation in cervical cancer screening participation & outcomes among Indigenous and non-Indigenous Australians in Queensland. Geographical Research.
- Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program. Vaccine.
- Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012). PLoS One.
- Safety of human papillomavirus vaccines: An updated review. Drug Saf.
- National Cervical Screening Programme Annual Report 2015. National Screening Unit: Wellington.
- Authors’ reply to “Comments on: Safety of Human Papillomavirus Vaccines: An Updated Review”. Drug Saf.
- Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination. Journal of Infectious Diseases.
- Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia. PLoS ONE.
- Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia. BMJ Open.
- A prospective study of the incidence of juvenile onset recurrent respiratory papillomatosis after implementation of a National HPV Vaccination Program. J Infect Dis.
- Australia on-track to be the first country to achieve cervical cancer elimination.
- Self-collection for under-screened women as part of the renewed National Cervical Screening Program: A Pilot Study. Current Oncology.
- Completing the cervical screening pathway: An Australian pilot of HPV self-collection for under-screened and never-screened women. Current Oncology.
- Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia. Commun Dis Intell.
- Innovative approaches to cervical cancer screening in low- and middle-income countries. Climacteric.
- Ambiguous bodies, uncertain diseases: knowledge of cervical cancer in Papua New Guinea. Ethn Health.
- “Lest we forget” as we move forward with cervical screening. Aust N Z J Obstet Gynaecol.
2017
- Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. PLoS Med.
- Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985-2013 in all women and in Māori women. Cancer Causes & Control.
- How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. Int J Cancer.
- Reply to Dikkers and San Giorgi. Journal of Infectious Diseases.
- Prevention of infection-related cancers. [book chapter] In 4th edition of Cancer Epidemiology and Prevention. Oxford University Press.
- Not all HPV nucleic acid tests are equal: only those calibrated to detect high grade lesions matter for cervical screening. [letter] Clin Microbiol Infect.
- A new era for cervical screening in Australia: Watch this space! Aust N Z J Obstet Gynaecol.
- Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia. Pap Research.
- Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. Lancet Public Health.
- Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia. PLoS One.
- Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study. BMJ Open.
- Human Papillomavirus Prevalence in Unvaccinated Heterosexual Men After a National Female Vaccination Program. J Infect Dis.
- Comparing human papillomavirus vaccine concerns on Twitter: a cross-sectional study of users in Australia, Canada and the UK. BMJ Open.
- Canadian school-based HPV vaccine programs and policy considerations. Vaccine.
- Time to clinical investigation after a high-grade abnormal Pap test for indigenous and non-indigenous women in Queensland, 2000–2011. Med J Aust.
